단일광자방출 컴퓨터단층촬영(SPECT) 시장 규모는 2024년 18억 8,000만 달러로 평가되며, 2024년부터 2031년까지 연평균 6.70% 성장하여 2031년에는 31억 5,000만 달러에 달할 것으로 예측됩니다. 단일광자방출 컴퓨터단층촬영(SPECT) 시장은 SPECT 기술의 발전과 전 세계 심장 질환 및 암 발병률의 증가로 인해 확대되고 있습니다. 또한, 현대식 진단 시설에 대한 투자 증가와 진단에 대한 사람들의 지식 증가가 SPECT 산업의 성장을 뒷받침하고 있습니다. 세계 단일광자방출 컴퓨터단층촬영(SPECT) 시장 보고서는 시장의 전반적인 평가를 제공합니다. 주요 부문, 동향, 시장 촉진요인, 억제요인, 경쟁 상황, 시장에서 중요한 역할을 하는 요인 등을 포괄적으로 분석합니다.
세계 단일광자방출 컴퓨터단층촬영(SPECT) 시장의 정의
단일광자방출 컴퓨터단층촬영(SPECT)이라는 영상검사는 다양한 장기와 조직으로 가는 혈액의 흐름을 파악할 수 있는 검사입니다. 심혈관질환, 암, 신경 질환, 뇌졸중, 발작, 스트레스 골절, 감염, 척수 종양 등을 확인하는 데 활용됩니다. 핵의학 영상 검사에서는 방사성 추적자와 컴퓨터 단층촬영(CT)이 진단에 사용됩니다. 방사성 표지 추적자는 CT 스캐너가 감지할 수 있는 감마선을 방출하여 의료 전문가가 조직과 장기로의 혈액 흐름을 검사할 수 있도록 합니다. 컴퓨터는 감마선 방출에서 데이터를 수집하여 CT 단면에 표시합니다. 이 단면도를 통해 뇌와 다른 장기를 3차원으로 볼 수 있습니다.
SPECT에는 테크네튬-99m, 탈륨-201, 오딘-123, 불소-18, 크세논-133 등의 방사성 동위원소가 사용됩니다. 뇌와 척추의 동맥과 정맥을 통한 혈류는 SPECT 스캔으로 감지할 수 있으며, SPECT는 환부로 가는 혈류 감소를 확인하기 위해 활용되기 때문에 MRI나 CT 스캔보다 뇌 손상에 대해 더 정확한 소견을 얻을 수 있다는 연구 결과가 있습니다. 심장 혈류는 심장 SPECT 스캔으로 검사할 수 있습니다. 혈류가 부족한 심장 부위는 어둡게 보이고, 혈류가 정상인 부위는 밝게 보입니다. 또한, 스트레스 골절이나 골절 부목 등 발견되지 않은 골절을 진단하는 데에도 사용됩니다.
세계 단일광자방출 컴퓨터단층촬영(SPECT) 시장 개요
악성 종양, 심혈관질환 및 기타 심각한 질병을 앓고 있는 환자가 증가함에 따라 시장이 확대되고 있습니다. 시장은 주로 급성장하는 헬스케어 산업이 주도하고 있습니다. 고령화와 좌식 생활습관으로 인한 질병이 만연하고 있어 시장 확대가 예상됩니다. 또한, SPECT 장비의 진단 능력의 발전은 듀얼 모달리티 및 장기별 시스템 사용의 증가로 인해 SPECT 장비의 진단 능력이 향상되고 있는 것도 큰 요인으로 작용하고 있습니다. 시장 확대를 촉진하는 또 다른 요소는 관상동맥 질환의 증가입니다. 현재 하이브리드 SPECT 이미징 시스템에 대한 수요가 증가하고 있습니다. 시장 확대를 촉진하는 또 다른 두 가지 요인은 방사성의약품 생산에 대한 연구 확대와 이 검사 유형이 다른 이미징 기술에 비해 여러 가지 이점에 대한 일반 지식의 증가입니다. 새로운 방사성 추적자의 개발과 시스템 설계의 지속적인 기술 개선은 시장 확대를 더욱 촉진하고 있습니다. 갈륨-67은 종양 진단 및 병기 결정의 표준입니다. 하이브리드 이미징에서 Ga-67 SPECT/CT를 사용하면 림프종 병변을 정확하게 식별할 수 있습니다.
Ga-67은 금속-트랜스페린 복합체로서 염증 조직에 특이적으로 집중되지 않고 이후 트랜스페린 수용체에 추가로 결합하는 능력이 있기 때문에 염증 이미징에 자주 사용되는 약물입니다. Nuclear 등 많은 시장 진입자들이 구연산 갈륨 GA-67을 제공하고 있습니다. 그 결과, 갈륨-67의 장점뿐만 아니라 다양한 암과 뼈 질환의 빈도가 증가함에 따라 예측 기간 동안 시장이 빠르게 확대되어 비즈니스 잠재력을 제시할 것으로 예상됩니다. 분자 동위원소는 영상 진단 장비에 필요하지만, 예측 기간 동안 공급 부족과 가용성 부족으로 인해 세계 SPECT 시장의 확장을 억제할 것으로 예측됩니다. 일례로, 심장학에서 많은 SPECT 시술에 사용되는 테크네튬과 몰리브덴은 지난 몇 년 동안 여러 차례 공급 부족 사태가 발생했습니다.
분자 동위원소 공급에 영향을 미친 또 다른 요인은 동위원소를 공급하는 원자로가 안전 문제로 인해 일부 지역에서 무기한 가동이 중단된 것입니다. 제품 리콜도 SPECT 세계 시장을 괴롭히는 요인 중 하나입니다. 심혈관질환, 암, 뇌 기능 장애와 같은 병변, 질병, 장기 기능 장애에 대한 SPECT 장비의 적용은 재병기, 진단, 병기, 경과 관찰에 부정적인 영향을 미치며, SPECT 장비 세계 시장은 제품 리콜 및 SPECT 장비로 인한 부정적인 영향으로 인해 수익 증가에 어려움을 겪고 있습니다.
Single-Photon Emission Computed Tomography (SPECT) Market size was valued at USD 1.88 Billion in 2024 and is projected to reach USD 3.15 Billion by 2031, growing at a CAGR of 6.70% from 2024 to 2031. The Single-Photon Emission Computed Tomography (SPECT) Market is expanding as a result of developments in SPECT technology as well as the rising incidence of cardiac and cancer disorders worldwide. Furthermore, increased investment in modern diagnostic facilities and rising knowledge among people regarding diagnosis are supporting the growth of the SPECT Industry. The Global Single-Photon Emission Computed Tomography (SPECT) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Single-Photon Emission Computed Tomography (SPECT) Market Definition
An imaging examination called a single photon emission computed tomography (SPECT) reveals how blood flows to various organs and tissues. It is utilized to identify cardiovascular problems, cancer, and neurological conditions as well as strokes, seizures, stress fractures, infections, and spinal tumours. A radioactive tracer and computed tomography (CT) are used in a nuclear imaging scan to provide a diagnosis. The radiolabeled tracer allows medical professionals to examine how blood flows to tissues and organs by emitting gamma rays that the CT scanner can detect. Computers gather data from the gamma-ray emissions, which are then shown on the CT cross-sections. The brain and other organs are shown in three dimensions using these cross-sections.
In the SPECT, radioisotopes including technetium-99m, thallium-201, odine-123, fluorine-18, and xenon-133 are used. Blood flow via arteries and veins in the brain and spine can be detected with a SPECT scan. Studies have demonstrated that because it is utilized to identify decreased blood flow to affected regions, it may provide more accurate findings for brain injury than MRI or CT scanning. The blood flow through the heart is examined using cardiac SPECT scans; regions of the heart with inadequate blood flow will look dark, while parts with normal blood flow will appear bright. Furthermore, it is used to diagnose undetected bone fractures, such as stress fractures and shin splints.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Single-Photon Emission Computed Tomography (SPECT) Market Overview
The market is growing because of the increase in individuals suffering from malignancies, cardiovascular diseases, and other critical ailments. The market is primarily driven by the quickly growing healthcare industry. The market is expected to expand because of ageing populations and the prevalence of ailments brought on by a sedentary lifestyle. The development of SPECT equipment's diagnostic capabilities has also been considerably aided by the rising usage of dual-modality and organ-specific systems throughout time. Another element driving market expansion is the rise in coronary artery diseases. The need for hybrid SPECT imaging systems is currently increasing. Two other factors that encourage expansion are expanding research into the production of radiopharmaceuticals and increasing public knowledge of the multiple benefits that the testing type has over other imaging techniques. The development of new radiotracers and ongoing technological improvements in system design further boost market expansion. Gallium-67 is the gold standard for tumour diagnosis and staging. Using Ga-67 SPECT/CT in hybrid imaging, lymphoma lesions may be accurately identified.
Ga-67 is a commonly used agent for the imaging of inflammation because of its ability to concentrate not specifically in inflamed tissues as a metal-transferrin complex, followed by further binding to transferrin receptors. A number of market participants, including Lantheus Medical Imaging and Mallinckrodt Nuclear, provides gallium citrate GA-67. Consequently, it is projected that the market would expand rapidly during the forecast period and present business possibilities as a result of the rising frequency of different cancers and bone conditions as well as the benefits of gallium-67. Molecular isotopes are required for diagnostic imaging equipment, however, throughout the anticipated period, a shortage of supply and insufficient availability of these isotopes is predicted to restrain the expansion of the global SPECT market. As an example, there have been multiple supply shortages for the two chemical elements technetium and molybdenum during the past few years, which are often utilized in a significant number of SPECT procedures in cardiology.
An additional factor that has had an impact on the supply of molecular isotopes is the fact that the reactors that provided the isotopes were indefinitely shut down in some regions owing to safety-related concerns. Recalls of products are another factor that is hurting the global market for SPECT. The application of SPECT equipment for lesions, illnesses, and organ dysfunctions, such as cardiovascular disease, cancer, and brain dysfunction, has adverse effects on restaging, diagnosis, staging, and follow-up. The global market for SPECT devices is having problems increasing its revenue because of product recalls and the negative impacts of SPECT devices.
The Global Single-Photon Emission Computed Tomography (SPECT) Market is segmented on the basis of Product, Application, End-User, And Geography.
Based on Product, the market is bifurcated into Standalone SPECT and Hybrid SPECT. The Standalone SPECT technology segment accounted for the largest market share in 2022 and is projected to grow at a significant CAGR during the forecast period. The segment's expansion is driven by cancer and heart divisions' increasing use of Standalone SPECT. Gamma ray-based nuclear medicine imaging systems are a type of standalone SPECT. The device can produce high-quality full-body tomographic pictures in real time and detects the gamma-ray emissions from an injected radioisotope to provide images for diagnosis and illness management.
Based on Application, the market is bifurcated into Cardiology, Oncology, General Imaging, Neurology, and Other. The segment cardiology accounted for the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. Cardiologists use SPECT to see the different parts of the heart's blood flow. By administering a radioactive tracer that has been tagged with gamma cameras, doctors can examine where and how well blood flows into and around the heart. These let doctors determine whether conditions like atherosclerosis, coronary artery disease, hypertension, valvular illnesses like mitral valve prolapse, congenital bicuspid valves caused by an infection in early childhood, etc. have negatively impacted a patient's heart. The segment is expanding as a result of the globalization of cardiovascular diseases as well as increased public knowledge of heart disease diagnostics.
Based on End-User, the market is segmented into hospitals, diagnostic imaging centers, and ambulatory surgical centers. Hospitals segment accounted for the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. The market is expected to expand as a result of ageing populations and the prevalence of ailments brought on by a sedentary lifestyle. The development of SPECT equipment's diagnostic capabilities has also been considerably aided by the rising usage of dual-modality and organ-specific systems throughout time.
Based on regional analysis, the Global Single-Photon Emission Computed Tomography (SPECT) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share and is projected to grow at a significant CAGR during the forecast period. The region's big ageing population, high prevalence of cancer cases, and high number of cardiac patients are all driving the growth of the SPECT market there.
Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.